Tecogalan sodium inhibits corneal neovascularization induced by basic fibroblast growth factor

T. Murata, Tatsuro Ishibashi, H. Yoshikawa, A. Khalil, H. Inomata

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The antiangiogenic effect of tecogalan sodium on corneal neovascularization was investigated. Tecogalan sodium, a sulfated polysaccharide peptidoglycan complex isolated from an Arthrobacter species, has been reported to inhibit angiogenesis induced by basic fibroblast growth factor (bFGF) as well as tumor angiogenesis related to Kaposi's sarcoma. Corneal neovascularization induced by bFGF was inhibited by tecogalan sodium in a dose-dependent manner. Since bFGF is known to have a promoting effect on corneal neovascularization, tecogalan sodium may be a possible therapeutic agent for corneal neovascularization, which can cause severe visual disturbances.

Original languageEnglish
Pages (from-to)330-334
Number of pages5
JournalOphthalmic Research
Volume27
Issue number6
DOIs
Publication statusPublished - Jan 1 1995

Fingerprint

Corneal Neovascularization
Fibroblast Growth Factor 2
Arthrobacter
Peptidoglycan
Kaposi's Sarcoma
Polysaccharides
tecogalan
Neoplasms

All Science Journal Classification (ASJC) codes

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Tecogalan sodium inhibits corneal neovascularization induced by basic fibroblast growth factor. / Murata, T.; Ishibashi, Tatsuro; Yoshikawa, H.; Khalil, A.; Inomata, H.

In: Ophthalmic Research, Vol. 27, No. 6, 01.01.1995, p. 330-334.

Research output: Contribution to journalArticle

Murata, T. ; Ishibashi, Tatsuro ; Yoshikawa, H. ; Khalil, A. ; Inomata, H. / Tecogalan sodium inhibits corneal neovascularization induced by basic fibroblast growth factor. In: Ophthalmic Research. 1995 ; Vol. 27, No. 6. pp. 330-334.
@article{090fc83deb8e43bf9b8698005c799d2e,
title = "Tecogalan sodium inhibits corneal neovascularization induced by basic fibroblast growth factor",
abstract = "The antiangiogenic effect of tecogalan sodium on corneal neovascularization was investigated. Tecogalan sodium, a sulfated polysaccharide peptidoglycan complex isolated from an Arthrobacter species, has been reported to inhibit angiogenesis induced by basic fibroblast growth factor (bFGF) as well as tumor angiogenesis related to Kaposi's sarcoma. Corneal neovascularization induced by bFGF was inhibited by tecogalan sodium in a dose-dependent manner. Since bFGF is known to have a promoting effect on corneal neovascularization, tecogalan sodium may be a possible therapeutic agent for corneal neovascularization, which can cause severe visual disturbances.",
author = "T. Murata and Tatsuro Ishibashi and H. Yoshikawa and A. Khalil and H. Inomata",
year = "1995",
month = "1",
day = "1",
doi = "10.1159/000267744",
language = "English",
volume = "27",
pages = "330--334",
journal = "Ophthalmic Research",
issn = "0030-3747",
publisher = "S. Karger AG",
number = "6",

}

TY - JOUR

T1 - Tecogalan sodium inhibits corneal neovascularization induced by basic fibroblast growth factor

AU - Murata, T.

AU - Ishibashi, Tatsuro

AU - Yoshikawa, H.

AU - Khalil, A.

AU - Inomata, H.

PY - 1995/1/1

Y1 - 1995/1/1

N2 - The antiangiogenic effect of tecogalan sodium on corneal neovascularization was investigated. Tecogalan sodium, a sulfated polysaccharide peptidoglycan complex isolated from an Arthrobacter species, has been reported to inhibit angiogenesis induced by basic fibroblast growth factor (bFGF) as well as tumor angiogenesis related to Kaposi's sarcoma. Corneal neovascularization induced by bFGF was inhibited by tecogalan sodium in a dose-dependent manner. Since bFGF is known to have a promoting effect on corneal neovascularization, tecogalan sodium may be a possible therapeutic agent for corneal neovascularization, which can cause severe visual disturbances.

AB - The antiangiogenic effect of tecogalan sodium on corneal neovascularization was investigated. Tecogalan sodium, a sulfated polysaccharide peptidoglycan complex isolated from an Arthrobacter species, has been reported to inhibit angiogenesis induced by basic fibroblast growth factor (bFGF) as well as tumor angiogenesis related to Kaposi's sarcoma. Corneal neovascularization induced by bFGF was inhibited by tecogalan sodium in a dose-dependent manner. Since bFGF is known to have a promoting effect on corneal neovascularization, tecogalan sodium may be a possible therapeutic agent for corneal neovascularization, which can cause severe visual disturbances.

UR - http://www.scopus.com/inward/record.url?scp=0029583096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029583096&partnerID=8YFLogxK

U2 - 10.1159/000267744

DO - 10.1159/000267744

M3 - Article

C2 - 8927305

AN - SCOPUS:0029583096

VL - 27

SP - 330

EP - 334

JO - Ophthalmic Research

JF - Ophthalmic Research

SN - 0030-3747

IS - 6

ER -